Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

99999 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-08-31

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate that a hypo-fractionated course of radiotherapy (ie. an accelerated radiotherapy course where fewer but larger doses of radiotherapy are given) is both safe and effective in the treatment of low-risk localized prostate cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

NCT07325721

Prostate Cancer Prostate Cancer Patients Treated by Radiotherapy

RECRUITING PHASE2

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

NCT00331773

Prostate Cancer

COMPLETED PHASE3

Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate

NCT01508390

Prostate Cancer

ACTIVE_NOT_RECRUITING NA

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

NCT00619515

Prostate Cancer

TERMINATED NA

Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer

NCT00714753

Prostate Cancer

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostatic Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hypo-fractionated Radiotherapy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have had any form of prior curative treatment (surgery, radiotherapy, cryotherapy) will not be eligible. A prior course of hormone therapy of less than 3 months duration will be allowed.
* Adult men will be considered.
* No life expectancy restrictions will apply.
* Performance Status will not be considered.
* No requirements for organ or marrow function will be made

Exclusion Criteria

* The use of other concurrent Investigational Agents will not be allowed.
* No exclusion requirements due to co-morbid disease or incurrent illness.
* No requirements regarding history of allergic reactions.
* Pregnancy or nursing patients is not applicable (ie. patients are male).

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No